News

The GOG Foundation, Inc., the Society of Gynecologic Oncology, and the Foundation for Women’s Cancer announce synergistic partnership to advance the missions of all three organizations

News // General
November 1, 2022

FOR IMMEDIATE RELEASE
Nov. 1, 2022

The GOG Foundation, Inc., the Society of Gynecologic Oncology, and the Foundation for Women’s Cancer announce synergistic partnership to advance the missions of all three organizations
 

Philadelphia, PA and Chicago, IL USA, Nov. 1, 2022 – The GOG Foundation, Inc. (GOG-F), the Society for Gynecologic Oncology (SGO) and the Foundation for Women’s Cancer (FWC) are elevating their shared dedication to improving patient outcomes and accelerating cancer research through strategic partnership in three critical areas: research and career advancement; diversity, inclusion and health equity; and industry relations.

GOG-F, SGO and FWC representatives* first assessed opportunities for increased collaboration in a July retreat, during which participants were guided by three objectives: to delineate the collective mission and identify future strategic objectives specific to each organization to promote key initiatives; to identify synergistic opportunities for collaboration; and to develop operational roadmaps and workstreams to achieve collaborative objectives and define metrics for success. Organizational leaders from the three organizations engaged in one-to-one and group conversations to achieve meeting objectives. At the close of the retreat, participants collectively recognized an integral next step to develop a dynamic and diverse GOG/SGO/FWC steering committee that could provide continual partnership oversight and guidance. Organization representatives for the steering committee were then selected and appointed**, and now are actively meeting to move the partnership forward.

Larry Copeland, MD, GOG-F President, reflected on initial partnership meetings, stating, “The opportunity to meet with our SGO and FWC colleagues only further supports the GOG Foundation’s mission to positively impact patients through the prevention and treatment of gynecologic malignancies. The collaboration with SGO and FWC will help us find solutions for our patients through clinical trials and translational research.”

Click here to view the full press release.